109 related articles for article (PubMed ID: 23354299)
1. Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts.
Lin JC; Huang WP; Liu CL; Lee JJ; Liu TP; Ko WC; Huang YC; Hsu ML; Wu CH; Chen YJ
Transplantation; 2013 Mar; 95(6):791-800. PubMed ID: 23354299
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib induces autophagy and suppresses activation of human macrophage.
Lin JC; Liu CL; Lee JJ; Liu TP; Ko WC; Huang YC; Wu CH; Chen YJ
Int Immunopharmacol; 2013 Feb; 15(2):333-9. PubMed ID: 23337882
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib-induced defective autophagy promotes cell death by necroptosis.
Kharaziha P; Chioureas D; Baltatzis G; Fonseca P; Rodriguez P; Gogvadze V; Lennartsson L; Björklund AC; Zhivotovsky B; Grandér D; Egevad L; Nilsson S; Panaretakis T
Oncotarget; 2015 Nov; 6(35):37066-82. PubMed ID: 26416459
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways.
Hao H; Zhang D; Shi J; Wang Y; Chen L; Guo Y; Ma J; Jiang X; Jiang H
Anticancer Drugs; 2016 Mar; 27(3):192-203. PubMed ID: 26629768
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF-beta signal.
Wang Q; Yu T; Yuan Y; Zhuang H; Wang Z; Liu X; Feng M
J Surg Oncol; 2013 Mar; 107(4):422-7. PubMed ID: 22833259
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.
Liu X; Sun K; Wang H; Dai Y
Cell Mol Neurobiol; 2016 Oct; 36(7):1197-208. PubMed ID: 26971793
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival.
Hsieh CH; Liao HF; Kuo CD; Huang YC; Shueng PW; Hsu YP; Wang LY; Tsai TH; Chen YJ
Transplantation; 2011 Oct; 92(8):848-57. PubMed ID: 21876479
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.
Yi H; Ye T; Ge M; Yang M; Zhang L; Jin S; Ye X; Long B; Li L
Oncol Rep; 2018 Feb; 39(2):711-720. PubMed ID: 29207150
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
11. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
12. Novel sorafenib-based structural analogues: in-vitro anticancer evaluation of t-MTUCB and t-AUCMB.
Wecksler AT; Hwang SH; Wettersten HI; Gilda JE; Patton A; Leon LJ; Carraway KL; Gomes AV; Baar K; Weiss RH; Hammock BD
Anticancer Drugs; 2014 Apr; 25(4):433-46. PubMed ID: 24525589
[TBL] [Abstract][Full Text] [Related]
13. Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis.
Yang YY; Huang YT; Lee TY; Chan CC; Yeh YC; Lee KC; Lin HC
Liver Transpl; 2012 Nov; 18(11):1371-83. PubMed ID: 22847887
[TBL] [Abstract][Full Text] [Related]
14. Targeting autophagy enhances BO-1051-induced apoptosis in human malignant glioma cells.
Chu PM; Chen LH; Chen MT; Ma HI; Su TL; Hsieh PC; Chien CS; Jiang BH; Chen YC; Lin YH; Shih YH; Tu PH; Chiou SH
Cancer Chemother Pharmacol; 2012 Mar; 69(3):621-33. PubMed ID: 21947203
[TBL] [Abstract][Full Text] [Related]
15. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib prolongs liver regeneration after hepatic resection in rats.
Mollbrink A; Augsten M; Hultcrantz R; Eriksson LC; Stål P
J Surg Res; 2013 Oct; 184(2):847-54. PubMed ID: 23726434
[TBL] [Abstract][Full Text] [Related]
17. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
[TBL] [Abstract][Full Text] [Related]
18. [Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance].
Yu S; He X; Hu A; Fu BM; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):399-402. PubMed ID: 18359700
[TBL] [Abstract][Full Text] [Related]
19. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
20. RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver.
Shi JH; Liu SZ; Wierød L; Scholz H; Anmarkrud JA; Huitfeldt HS; Zhang SJ; Line PD
J Surg Oncol; 2013 Mar; 107(4):393-401. PubMed ID: 22927239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
